Tianjin Medical University Cancer Institute and Hospital
Tianjin Medical University Cancer Institute and Hospital
Tianjin, Tianjin Municipality, China13 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study on the Efficacy of Different Doses of Oryz-Aspergillus Enzyme And Pancreatin Tablet in Treating Pancreatic Exocrine Insufficiency After Gastrointestinal Surgery | Digestive System Diseases, exocrine pancreatic insufficiency, pancreas disorder | Not yet recruiting | Not applicable | 2026-08-07 | NCT07751367 | |
| Toripalimab-based Neoadjuvant Therapy in LA-HNSCC | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma | Active, not recruiting | Phase 2 | 2026-07-17 | NCT05522985 | |
| Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer | Pancreatic cancer, adult | Recruiting | Phase 3 | 2026-07-10 | NCT07436741 | |
| Preliminary Trial of SNA014 for Pancreatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Early phase 1 | 2026-05-19 | NCT07597772 | |
| A Preliminary Efficacy of SNA028 in Patients With Advanced Colorectal Cancer Positive for GPA33 | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Not yet recruiting | Early phase 1 | 2026-05-15 | NCT07590856 | |
| Iparomlimab and Tuvonralimab Injection Combined With SBRT in Patients With Early-Stage Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Not yet recruiting | Phase 2 | 2026-04-29 | NCT07379398 | |
| Clinical Study on the Efficacy and Safety of Iparomlimab and Tuvonralimab Injection Combined With Nab-Paclitaxel in Neoadjuvant Therapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma | esophageal squamous cell carcinoma | Not yet recruiting | Phase 2 | 2026-03-27 | NCT07493993 | |
| A Single-center Phase II Study to Investigate the Immune Maintenance Therapy Pattern in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Achieved MPR After Neoadjuvant Immunotherapy Combined With Chemotherapy | Head and Neck Neoplasms, Neoplasms by Site, head and neck cancer, neoplasm | Recruiting | Phase 2 | 2026-03-03 | NCT06208826 | |
| Iparomlimab and Tuvonralimab Injection Combined With GemOX and Lenvatinib as Conversion Therapy for Initially Potentially Resectable Intrahepatic Cholangiocarcinoma and Gallbladder Cancer | BTC | Not yet recruiting | Phase 2 | 2025-12-04 | NCT07263360 | |
| Lparomlimab and Tuvonralimab Injection in Combination With TACE and Lenvatinib in the Treatment of Second-Line Therapy for Unresectable Intermediate-to-Advanced Hepatocellular Carcinoma | hepatocellular carcinoma | Recruiting | Phase 2 | 2025-08-29 | NCT07099274 | |
| Toripalimab Therapy After Resection in High-risk Stage IA2-IB NSCLC With no Driver Alterations (EGFR or ALK) | non-small cell lung carcinoma | Recruiting | Phase 2 | 2025-04-01 | NCT06221670 | |
| TAA06 Injection in the Treatment of Patients With B7-H3-positive Relapsed/ Refractory Neuroblastoma | B7-H3-positive Relapsed/ Refractory Neuroblastoma | Recruiting | Phase 1 | 2023-02-27 | NCT05562024 | |
| Neck Dissection vs Radiotherapy for Cervical Metastases in Advanced Hypopharyngeal Cancer | Head and Neck Neoplasms, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, hypopharyngeal carcinoma, neoplasm, otorhinolaryngologic disease | Not yet recruiting | Not applicable | 2017-12-12 | NCT03367884 |